FT Live | De-Risking Investment to Deliver Innovation
In this panel session at the FT Live: Funding Biopharma Innovation event, Anshu Sawhney, VP, Global Medical Affairs Head of Syneos One®, discusses the current funding environment and why biopharma companies should be optimistic.
*Footage provided by Financial Times Live.
Related Content
Looking for exclusive insight?
